These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 24487593

  • 1. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M, Matsubara T, Kakuda Y, Sato Y, Nakanuma Y.
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [Abstract] [Full Text] [Related]

  • 2. Cellular senescence in biliary pathology. Special emphasis on expression of a polycomb group protein EZH2 and a senescent marker p16INK4a in bile ductular tumors and lesions.
    Sasaki M, Nakanuma Y.
    Histol Histopathol; 2015 Mar; 30(3):267-75. PubMed ID: 25289642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
    Sasaki M, Matsubara T, Yoneda N, Nomoto K, Tsuneyama K, Sato Y, Nakanuma Y.
    Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606
    [Abstract] [Full Text] [Related]

  • 5. Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis.
    Kim SK, Kim SR, Imoto S, Kim CW, Matsuoka T, Sasaki M, Nakashima O, Kumabe T, Hayashi Y.
    Pathol Int; 2016 Sep; 66(9):543-5. PubMed ID: 27418411
    [No Abstract] [Full Text] [Related]

  • 6. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.
    Sempoux C, Fan C, Singh P, Obeidat K, Roayaie S, Schwartz M, Fiel MI, Thung SN.
    Semin Liver Dis; 2011 Feb; 31(1):104-10. PubMed ID: 21344355
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S, Okabe H, Sakamoto Y, Hayashi H, Hashimoto D, Yokoyama N, Sakamoto K, Kuroki H, Mima K, Nitta H, Imai K, Chikamoto A, Watanabe M, Beppu T, Baba H.
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [Abstract] [Full Text] [Related]

  • 9. Elevated expression of Bmi1 in hepatocellular carcinoma with bile duct tumor thrombi.
    Zhang R, Xu LB, Zeng H, Yu XH, Wang J, Liu C.
    Hepatogastroenterology; 2013 Dec; 60(128):2042-7. PubMed ID: 24719948
    [Abstract] [Full Text] [Related]

  • 10. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M, Sato Y, Nakanuma Y.
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [Abstract] [Full Text] [Related]

  • 11. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.
    Sasaki M, Sato Y, Nakanuma Y.
    Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
    [Abstract] [Full Text] [Related]

  • 12. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
    Bertram S, Padden J, Kälsch J, Ahrens M, Pott L, Canbay A, Weber F, Fingas C, Hoffmann AC, Vietor A, Schlaak JF, Eisenacher M, Reis H, Sitek B, Baba HA.
    J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014
    [Abstract] [Full Text] [Related]

  • 13. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
    Schlitter AM, Born D, Bettstetter M, Specht K, Kim-Fuchs C, Riener MO, Jeliazkova P, Sipos B, Siveke JT, Terris B, Zen Y, Schuster T, Höfler H, Perren A, Klöppel G, Esposito I.
    Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
    [Abstract] [Full Text] [Related]

  • 14. An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy.
    Sasaki M, Sato Y.
    Virchows Arch; 2021 Oct; 479(4):697-703. PubMed ID: 34115196
    [Abstract] [Full Text] [Related]

  • 15. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA, Ahmed NS.
    Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165
    [Abstract] [Full Text] [Related]

  • 16. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.
    Semin Liver Dis; 2011 Feb 30; 31(1):49-60. PubMed ID: 21344350
    [Abstract] [Full Text] [Related]

  • 17. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM.
    J Gastroenterol Hepatol; 2010 Sep 30; 25(9):1485-92. PubMed ID: 20796144
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
    Balitzer D, Joseph NM, Ferrell L, Shafizadeh N, Jain D, Zhang X, Yeh M, di Tommaso L, Kakar S.
    Mod Pathol; 2019 Oct 30; 32(10):1486-1494. PubMed ID: 31186529
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
    Ryu HS, Lee K, Shin E, Kim SH, Jing J, Jung HY, Lee H, Jang JJ.
    Tumori; 2012 Oct 30; 98(4):478-84. PubMed ID: 23052165
    [Abstract] [Full Text] [Related]

  • 20. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K, Sasaki M, Fujii T, Harada K, Zen Y, Sato Y, Sawada S, Minato H, Matsui O, Nakanuma Y.
    Histopathology; 2007 Sep 30; 51(3):390-400. PubMed ID: 17553067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.